Your browser doesn't support javascript.
loading
Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
Chiba, Shiho; Halfmann, Peter J; Iida, Shun; Hirata, Yuichiro; Sato, Yuko; Kuroda, Makoto; Armbrust, Tammy; Spyra, Samuel; Suzuki, Tadaki; Kawaoka, Yoshihiro.
Affiliation
  • Chiba S; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
  • Halfmann PJ; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
  • Iida S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Hirata Y; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Sato Y; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kuroda M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
  • Armbrust T; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
  • Spyra S; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
  • Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan; The
Vaccine ; 41(41): 6025-6035, 2023 09 22.
Article in En | MEDLINE | ID: mdl-37635002

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Animals / Humans Language: En Journal: Vaccine Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Animals / Humans Language: En Journal: Vaccine Year: 2023 Document type: Article Affiliation country: Country of publication: